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ABSTRACT 
Colon specific drug delivery has gained increased importance not just for delivery of drug for the treatment of local diseases, associated with 
the colon but also potential site for systemic delivery of therapeutic drug. Indomethacin is non‐steroidal anti‐inflammatory drug with short 
half life. 
Indomethacin Microspheres were prepared by solvent evaporation method using Eudragit L‐100 and Eudragit S‐100 mixture [1:2, 1:3, 1:4, 
and 1:5] were used as pH‐sensitive polymers. The prepared Microspheres were evaluated for various physicochemical parameters such as 
particle size, percentage yield, incorporation efficiency, drug polymer compatibility (IR study), scanning electron microscopy (SCM) and 
drug release of Microsphere (pH 6.8) for 12 hrs. Result shows that as the concentration of polymer increases it affects the particle size, 
percentage yield and drug release of micro capsules. The flow properties were found to be good and scanning electron microscopy confirmed 
their hollow structure with smooth surface. Formulation F1 shows excellent particle size, percentage yield (90.24%), incorporation efficiency 
(95.59%) and percentage drug release (95.58%) for a period of 12 hrs. Results of our present study suggest that Indomethacin Microspheres 
can be successfully designed to develop sustained drug delivery, which can improve compliance by reducing dosing frequency. 
Keywords: Colon specific, Eudragit, Microspheres, Indomethacin. 
 
INTRODUCTION 
The word new or novel in the relation to drug delivery 
system  is a  search  for something out of  necessity.  An 
appropriately  designed  sustained  or  controlled  release 
drug delivery system can  be  major – advance towards 
solving  the  problem  associated  with  the  existing  drug 
delivery systems
1,  2. In recent year, colon targeted drug 
delivery  of  both  conventional  and  labile  molecule  is 
developed
3. It is a drug delivery site for the treatment of 
local disease, associated with colon like crohn’s disease, 
ulcerative colitis, irritable bowel syndrome, also it is a 
potential  site  for  systemic  delivery  of  therapeutic 
drugs
4,5. Colon is also found to be a promising site when 
delay in absorption is desirable from therapeutic point of 
view  for  the  treatment  of  disease  that  have  peak 
symptoms  in  early  morning  and  that  exhibit  circadian 
rhythm,  such  as  rheumatoid  arthritis  (RA),  nocturnal 
asthma  and  angina  pectoris
6,7.  In  case  of  rheumatoid 
arthritis, peak symptoms occur early in the morning due 
to  the  imbalance  between  anti‐inflammatory  effect  by 
cortical  and  pro-inflammatory  effects  exerted  by 
melaton
8. The widely used approaches for colon specific 
targeting  are  bacterially  triggered,  pressure  controlled, 
pH dependent and time dependent control drug delivery 
system3. The pH of colon is 6.5 and pH of intestine (7.00 
to 8.00)
9. Most commonly  used pH dependent coating 
polymers such as Eudragit (L100/S100) which dissolves 
at pH 6.00 and 7.00 respectively. 
Hence, none of these polymers are suitable to be used, 
alone for coating of dosage forms that would start release 
the  drug  at  pH  6.5,  although  this  has  been  generally 
accepted as the desired pH for colon targeted delivery
3. 
Indomethacin  [1,  1  –  biphenyl]  –  4‐acetic  acid, 
2‐fluro‐alpha‐methyl,  is  a  important  analgesic  and 
non‐steroidal anti‐inflammatory drug 
(NSAID)  also  with  anti‐pyretic  properties  whose 
mechanism of action  is the  inhibition of prostaglandin 
synthesis.  It  is  used  in  the  therapy  of  rheumatoid 
disorders.  Indomethacin  is  rapidly  eliminated  from  the 
blood, its plasma elimination half‐life is 3‐6 hours and in 
order  to  maintain  therapeutic  plasma  levels.  The  drug 
must be administered approximately 150‐200mg daily by 
oral  individual dosage
10. The aim of this  work was to 
develop  Microspheres  of  Indomethacin  by  solvent 
evaporation  technique.  Indomethacin  whose 
physicochemical  properties  and  short  half  life  make  it 
suitable candidate for colonic drug delivery system. 
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MATERIALS AND METHODS 
Indomethacin was obtained from Micro Lab Ltd. (India).  
pH sensitive meth acrylic acid co‐polymers (Eudragit® 
L‐100  and  S‐  100)  were  supplied  as  gifts  by  Degussa 
India Pvt. Ltd., Mumbai (India). Heavy liquid paraffin, 
Acetone, petroleum ether was obtained  from S.D.  fine 
Chem.  Ltd.,  Mumbai  (India),  Span  80  were  supplied 
from Ioba, Chemical, India, Ethanol were supplied from 
Jiangsu  Huaxi  International  Trade  Co.  Ltd.(Made  IN 
China),  All  other  chemicals  and  reagent  used  in  this 
study were of analytical grade. 
Method of preparation 
Microspheres  were  prepared  by  solvent  evaporation 
method. Accurately weighted Eudragit L‐100 and S‐100 
in different ratios were dissolved in 50ml of acetone to 
form  a  homogenous  polymers  solution.  Core  material, 
i.e.  Indomethacin  was  dispersed  in  it  and  mixed 
thoroughly.  This  organic  phase  was  slowly  poured  at 
15°C into liquid paraffin (100 ml) containing 1% (w/w) 
of Span‐80 with stirring at 1000 rpm to form a uniform 
emulsion.  Thereafter,  it  was  allowed  to  attain  room 
temperature  and  stirring  was  continued  until  residual 
acetone evaporated and smooth‐walled, rigid and discrete 
Microspheres  were  formed.  The  Microspheres  were 
collected  by  decantation  and  the  product  was  washed 
with petroleum ether (40– 60°C), four times and dried at 
room temperature for 3 hrs. The Microspheres were then 
stored in a desiccators over fused calcium chloride. 
Evaluation of indomethacin microspheres 
Micromeritic properties 
Particle size: 
Determination  of  average  particle  size  of  the 
Indomethacin  Microspheres  was  carried  out  by  the 
optical  microscopy  method.  A  minute  quantity  of 
Microspheres  was  spread  on  clean  glass  slide  and 
average sizes of 100 Microspheres were determined in 
each batch. 
Angle of repose:  
Determination  of  angle  of  repose  Indomethacin 
Microspheres  were  carried  out  by  employing  fixed 
funnel method. 
Angle of repose θ = tan‐1 (H/R) 
H = Height of the pile 
R = Radius of the pile 
Percentage yield 
The measured weight was divided by total amount of all 
non-volatile  components  which  were  used  for  the 
preparation of microsphere. 
% yield = Total weight of excipient and drug / Actual 
weight of product x 100 
 
Drug content uniformity 
In 100ml volumetric flask 25mg of crushed microspheres 
were taken and dissolved with small quantity of ethanol 
and the volume was made up to mark with pH 6.8 and 
stirred for 12 hrs. After stirring the solution was filtered 
through  whatman  filter  paper  and  from  the  filtrate 
appropriate  dilutions  were  made  and  absorbance  was 
measured  at  247  nm  by  using  Shimadzu  1700  UV 
spectrophotometer. 
Infrared spectroscopy (FT-IR) 
FT‐IR  spectra  of  the  Indomethacin,  F1  formulation, 
Eudragit  L‐100,  Eudragit  S‐100  using  KBr  pellet 
technique,  Samples  were  scanned  over  the 
500‐4000cm‐1 Spectral region at a resolution of 4cm‐
1. 
The ratio of the sample in KBr disc was 1% (shimadzu 
FT‐IR spectrometer). 
Scanning electron microscopy 
The  samples  for  SEM  analysis  were  prepared  by 
following  method.  Dry  Microspheres  brass  stub  an 
coated  with  gold  in  an  ion  sputter.  Then  picture  of 
Microspheres  were  taken  by  random  scanning  of  the 
stub. The SEM analysis or the Microspheres was carried 
out by using JEOL–6360A analytical scanning electron 
microscope (Physics Department pune University, pune 
(India)).  The  Microspheres  were  viewed  at  an 
accelerating voltage of 20KV. 
Drug release 
In  vitro  release  studies:  In  vitro  dissolution  profile  of 
each  formulation  was  determined  by  employing  USP 
XXIII  rotating  basket  method  (900  ml  of  pH 
6.8‐phosphate  buffer,  100  rpm,  37±0.5  ◦C). 
Microspheres equivalent to 150 mg of Indomethacin was 
loaded into the basket of the dissolution apparatus. Five 
milliliters  of  the  sample  was  withdrawn  from  the 
dissolution media at suitable time intervals and the same 
amount was replaced with fresh buffer. The absorbance 
of the filtrate was determined at wavelength of 247 nm 
by using UV–vis spectrophotometer, against pH 6.8 as 
blank. 
RESULTS AND DISCUSSION 
Preparative aspects of Eudragit Microspheres 
To prepare pH dependent Microspheres the O/O (oil in 
oil)  emulsion  solvent  evaporation  technique  was  used 
since  it  yields  more  uniform  particles.  The  method  is 
correctly referred as O/O instead of W/O (water in oil) 
since  a  polymeric  solution  in  organic  solvent  is 
considered  as  oil  in  micro  encapsulation  terminology. 
The  organic  phase  containing  pH  dependent  Eudragit 
L/S‐100  mixture  [1:2,  1:3,  1:4,  1:5]  and  dispersed 
Indomethacin was emulsified into an external oil phase. 
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with 2% water fitted the criterion well. Liquid paraffin 
was  used  as  the  dispersion  media  or  external  phase. 
Petroleum ether was used to clean the microparticle since 
it removes liquid paraffin without affecting the integrity 
of the microparticle. 
Micromeritic properties 
The  arithmetic  mean  particle  size  of  the  formulations 
was determined by the optical microscope fitted with an 
ocular  micrometer  and  stage  micrometer.  The  average 
mean particle sizes 
of the Microspheres were found to be between 164.62 -
249.92.  The  mean  particle  size  of  the  Microspheres 
significantly  increased  with  increase  in  polymer 
concentration  due  to  high  viscosity  of  medium  at  a 
higher  polymer  concentration  resulting  in  enhanced 
interfacial  tension  and  diminished  shearing  efficiency. 
The angle of repose of Microsphere 
ranges from 18° 62”- 23° 36”  The values of angles of 
repose indicate excellent flow properties. 
Infrared spectroscopy 
The FT‐IR spectra study showed no change in the finger 
print of pure drug spectra, thus confirming absence of 
drug and polymer interaction. 
Scanning electron microscopy (SEM) 
Morphology of Microspheres was examined by scanning 
electron  microscopy.  The  view  of  the  Microspheres 
showed smooth surface morphology exhibited range of 
sizes  within  each  batch.  The  outer  surface  of 
Microspheres was smooth and dense, while the internal 
surface  was  porous.  The  shell  of  Microspheres  also 
showed  some  porous  structure  it  may  be  caused  by 
evaporation  of  solvent  entrapped  within  the  shell  of 
Microspheres after forming smooth and dense layer. 
Drug release 
In vitro release studies were carried out using USP XXIII 
dissolution assembly. The release profile obtained for all 
the  four  formulations  were  shown  in  Fig.  4.  It  was 
observed  that  the  drug  release  from  the  formulations 
decreased with increase in the amount of polymer added 
in each formulation. The release of drug from polymer 
matrix  takes  place  after  complete  swelling  of  the 
polymer and as the amount of polymer in the formulation 
increase the time required to swell also increase thereby 
decrease  in  the  drug  release.  However,  the  release 
showed a Bi-phases release with an initial burst effect At 
the  end  of  first  30  min.  drug  release  was  28.39%, 
26.23%, 26.36% and 24.10% for F1 to F4 respectively.  
The mechanism for the burst release can be attributed to 
the  drug  loaded  on  the  Microsphere  or  imperfect 
entrapment of drug. The mechanism for the burst release 
can be attributed to the drug loaded on the microsphere 
or imperfect entrapment of drug. The overall cumulative 
%  release  for  F1,  F2,  F3  and  F4,  were  found  to  be 
95.91%, 92.06%, 89.17%, and 87.81% at the end of 12th 
hour. 
CONCLUSION 
The  results  obtained  from  the  study  of  “Design  and 
evaluation of chronic-therapeutic drug delivery system of 
Indomethacin”  provide  the  following  conclusion:  The 
1:2 ratio of Eudragit L-100 and S-100 are suitable for 
preparation  of  microspheres  for  colonic  targeting.  The 
particle  size  increased  significantly  as  the  amount  of 
polymer  increased.  The  flow  properties  of  all  the 
prepared  microspheres  were  good  as  indicated  by  low 
angle  of  repose  (q  <  40º).The  good  flow  properties 
suggested  that  the  microspheres  produced  were  non-
aggregated. As the entrapment efficiency was good in all 
the cases, suggest that optimized parameters were used in 
the method of preparations. The In-vitro drug release of 
microspheres  exhibits  two  type  release  pattern  for  all 
microspheres with initial burst release effect, which may 
be attributed to the drug loaded onto the surface of the 
particles.  On  the  basis  of,  particle  size,  drug  content, 
Scanning Electron Microscopy, IR-study, in-vitro release 
studies  and  its  kinetic  data,  F3  was  selected  as  an 
optimized formulation for designing pulsatile device.  
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Table 1: Formulation of Indomethacin Microspheres 
Sl. 
No. 
 
Ingredients 
Formulation Code 
F1  F2  F3  F4 
1.  Drug (mg)  1000  1000  1000  1000 
2  Eudragit L-100 
(mg) 
166  333  500  666 
3.  Eudragit S-100 
(mg) 
332  666  1000  1332 
4.  Span-80 (ml)  0.5  0.5  0.5  0.5 
5.  Acetone (ml)  50  50  50  50 
 
Table 2: Micromeritic properties of Indomethacin Microspheres 
Formulation 
code 
Mean particles 
size(m m m mm) 
Angle of repose 
F1  164.62 ± 1.04  18° 75” ± 2.89 
F2  168.12 ± 1.21  18° 62” ± 1.79 
F3  195.99± 2.69  22° 09” ± 2.61 
F4  249.92 ± 1.91  23° 36” ± 2.99 
 
Table 3: Percentage yield and Drug content of Indomethacin microspheres 
Formulation 
code 
Percentage 
yield 
Drug content 
Uniformity 
F1  89.61 ± 0.40  82.79% ± 0.68 
F2  86.56 ± 0.27  88.23% ± 0.95 
F3  91. 54 ± 0.18  96.19% ± 0.28 
F4  88.85 ± 0.22  85.09% ± 0.16 
 
 
 
Fig. 1: Showing Microsphere of Indomethacin formulations(a) F1, (b) F2, (c) F3 (d) 
F4 
 
 
 
 
Figure 2: I.R. Spectrum of Pure Indomethacin and Indomethacin and polymers 
combination 
 
 
 
Figure 3: Scanning electron microphotographs of F3 formulation. 
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